Heat shock protein 47 (HSP47) is a collagen-specific molecular chaperone that is required for mo-lecular maturation of various types of collagens. Many studies have shown a close association be-tween increased expression of HSP47 and excessive accumulation of collagens in scar tissues of various human fibrotic diseases. However, the role of HSP47 in formation of scar after glaucoma filtration surgery is still unclear. In this study, we deleted the expression of HSP47 in human tent on fibroblasts (HTFs) by virus infection, and then the proliferation and collagen synthesis were compared between HSP47 deletion cells and control upon TGF-β1 stimulation. Our data showed that HSP47 deletion could significantly inhibit the proliferation and collagen synthesis of HTFs upon TGF-β1 stimulation, HSP47 gene suppression might be a novel method to against the formation of scar after glaucoma surgery.
References
[1]
Burr, J., Azuara-Blanco, A. and Avenell, A. (2005) Medical versus Surgical Interventions for Open Angle Glaucoma. Cochrane Database of Systematic Reviews, 18, CD004399.
[2]
Hitchings, R. (1998) Initial Treatment for Open-Angle Glaucoma-Medical, Laser, or Surgical? Surgery Is the Treatment of Choice for Open-Angle Glaucoma. Archives of Ophthalmology, 116, 241-242. http://dx.doi.org/10.1001/archopht.116.2.241
[3]
Roth, A., Muhlendyck, H. and De Gottrau, P. (2002) The Function of Tenon’s Capsule Revisited. J Fr Ophthalmol, 25, 968-976.
[4]
Cordeiro, M.F., Bhattacharya, S., Schultz, G.S. and Khaw, P.T. (2000) TGF-β1, -β2 and -β3 in Vitro: Biphasic Effects on Tenon’s Fibroblasts Contraction, Proliferation and Migration. Investigative Ophthalmology & Visual Science, 41, 756-763.
[5]
Lama, P.J. and Fechtner, R.D. (2003) Antifibrotic and Wound Healing in Glaucoma Surgery. Survey of Ophthalmology, 48, 314-346. http://dx.doi.org/10.1016/S0039-6257(03)00038-9
[6]
Georgopoulos, C. and Welch, W.J. (1993) Role of the Major Heat Shock Proteins as Molecular Chaperones. Annual Review of Cell and Developmental Biology, 9, 601-634. http://dx.doi.org/10.1146/annurev.cb.09.110193.003125
[7]
Tasab, M., et al. (2000) Hsp47: A Molecular Chaperone That Interacts with and Stabilizes Correctly-Folded Procollagen. EMBO Journal, 19, 2204-2211. http://dx.doi.org/10.1093/emboj/19.10.2204
[8]
Hulmes, D.J. (2002) Building Collagen Molecules, Fibrils, and Suprafibrillar Structures. Journal of Structural Biology, 137, 2-10. http://dx.doi.org/10.1006/jsbi.2002.4450
[9]
Ohba, S., et al. (2003) Antisense Oligonucleotide against 47-kDa Heat Shock Protein (Hsp47) Inhibits Wound-Induced Enhancement of Collagen Production. Archives of Oral Biology, 48, 627-633. http://dx.doi.org/10.1016/S0003-9969(03)00117-1
[10]
Nishino, T., et al. (2003) Antisense Oligonucleotides against Collagenbinding Stress Protein HSP47 Suppress Peritoneal Fibrosis in Rats. Kidney International, 64, 887-896. http://dx.doi.org/10.1046/j.1523-1755.2003.00169.x
[11]
Zha, Y., et al. (2006) Life-Long Suppression of Growth Hormone-Insulinlike Growth Factor-1 Activity in Genetically Altered Rats Could Prevent Age-Related Renal Damage. Endocrinology, 147, 5690-5698. http://dx.doi.org/10.1210/en.2006-0302
[12]
Razzaque, M.S., et al. (1999) Life-Long Dietary Restriction Modulates the Expression of Collagens and Collagen-Binding Heat Shock Protein 47 in Aged Fischer 344 Rat Kidney. The Histochemical Journal, 31, 123-132. http://dx.doi.org/10.1023/A:1003578928487
[13]
Raghu, G., et al. (1999) Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent, Pirfenidone: Results of a Prospective, Openlabel Phase II Study. American Journal of Respiratory and Critical Care Medicine, 159, 1061-1069. http://dx.doi.org/10.1164/ajrccm.159.4.9805017
[14]
Kakugawa, T., et al. (2004) Pirfenidone Attenuates Expression of HSP47 in Murine Bleomycin-Induced Pulmonary Fibrosis. European Respiratory Journal, 24, 57-65. http://dx.doi.org/10.1183/09031936.04.00120803
[15]
Razzaque, M.S. and Taguchi, T. (1999) The Possible Role of Colligin/HSP47, a Collagen-Binding Protein, in the Pathogenesis of Human and Experimental Fibrotic Diseases. Histology and Histopathology, 14, 1199-1212.
[16]
Xiao, H.B., Liu, R.H., Ling, G.H., Xiao, L., Xia, Y.C., Liu, F.Y., et al. (2012) HSP47 Regulates ECM Accumulation in Renal Proximal Tubular Cells Induced by TGF-Beta1 through ERK1/2 and JNK MAPK Pathways. American Journal of Physiology. Renal Physiology, 303, F757-F765. http://dx.doi.org/10.1152/ajprenal.00470.2011
[17]
Razzaque, M.S. and Taguchi, T. (2003) Factors That Influence and Contribute to the Regulation of Fibrosis. Contributions to Nephrology, 139, 1-11. http://dx.doi.org/10.1159/000071732
[18]
Iredale, J.P. (1996) Matrix Turnover in Fibrogenesis. Hepatogastroenterology, 43, 56-71.
[19]
Javerzat, S., et al. (2002) The Role of Fibroblast Growth Factors in Vascular Development. Trends in Molecular Medicine, 8, 483-489. http://dx.doi.org/10.1016/S1471-4914(02)02394-8
[20]
Kay, E.P., Lee, H.K., Park, K.S. and Lee, S.C. (1998) Indirect Mitogenic Effect of Transforming Growth Factor-b on Cell Proliferation of Subconjunctival Fibroblasts. Investigative Ophthalmology & Visual Science, 39, 481-486.
